Fulgent Genetics, Inc. (FLGT)
23.20
-0.06
(-0.28%)
USD |
NASDAQ |
Feb 20, 16:00
23.20
0.00 (0.00%)
After-Hours: 18:09
Fulgent Genetics EPS Diluted (Quarterly) : -0.2149 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Delcath Systems, Inc. | 0.0207 |
| Quest Diagnostics, Inc. | 2.18 |
| CytoSorbents Corp. | -0.0505 |
| Cardiac Biotech Solutions, Inc. | -0.0035 |
| Odyssey Health, Inc. | -0.0046 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.826M |
| Revenue (Quarterly) | 84.07M |
| Total Expenses (Quarterly) | 90.68M |
| Enterprise Value | 346.39M |
| Gross Profit Margin (Quarterly) | 39.83% |
| Profit Margin (Quarterly) | -8.12% |
| Earnings Yield | -6.04% |
| Normalized Earnings Yield | -5.060 |